. . . . . . . . . . . . "[NRR antibodies also strongly inhibit ligand-independent signaling in heterologous cells transiently expressing Notch1 receptors with diverse NRR class I point mutations, the most common type of mutation found in human T-cell acute lymphoblastic leukemia (T-ALL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2016-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2016-05-13T12:47:45+02:00"^^ . . . . . . . . . . . "v4.0.0.0" . "v4.0.0" .